Position in DXCM
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$691,210
-$31,866 QoQ
Shares Held
10,263
-10.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#533
of 966 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Merit Financial Group, LLC holds $35,235,370 across 29 Medical Devices names. DXCM ranks #10 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
25,858 | $8,141,126 | |
| 2 | ABT |
Abbott Laboratories
|
77,836 | $7,062,833 | |
| 3 | BSX |
Boston Scientific Corp
|
142,932 | $6,100,334 | |
| 4 | MDT |
Medtronic plc
|
64,678 | $5,059,754 | |
| 5 | EW |
Edwards Lifesciences Corp
|
14,863 | $1,344,503 | |
| 6 | PODD |
Insulet Corp
|
8,680 | $1,321,525 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
17,083 | $1,093,480 | |
| 8 | PHG |
Koninklijke Philips NV
|
33,359 | $907,028 |
All Filings in DXCM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $691,210 | 10,263 | Shares | Other | 2026-07-20 | |
| 2026-03-31 | $723,076 | 11,514 | Shares | Other | 2026-04-15 | |
| 2025-12-31 | $821,591 | 12,379 | Shares | Other | 2026-01-26 | |
| 2025-09-30 | $401,315 | 5,964 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $563,369 | 6,454 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $405,164 | 5,933 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $228,099 | 2,933 | Shares | Sole | 2025-01-15 | |
| 2024-03-31 | $225,664 | 1,627 | Shares | Sole | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||